Patients Relapsing Refractory Giant Cell Arteritis
1 clinical trials · Condition
◉ Watch Patients Relapsing Refractory Giant Cell Arteritis
| Record | Firm | Date |
|---|---|---|
| Ustekinumab for the Treatment of Relapse of Refractory Giant Cell Arteritis (NCT03711448) | Centre Hospitalier Universitaire Dijon | 2019-01-07 |
Track Patients Relapsing Refractory Giant Cell Arteritis automatically
Every clearance here is in the API, with alerts when new ones post.